(ICHR) Ichor Holdings - Ratings and Ratios
Gas Subsystems, Chemical Subsystems, Precision Components
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 65.3% |
| Value at Risk 5%th | 92.4% |
| Relative Tail Risk | -14.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.10 |
| Alpha | -82.02 |
| CAGR/Max DD | -0.15 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.471 |
| Beta | 2.662 |
| Beta Downside | 2.341 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.09% |
| Mean DD | 30.00% |
| Median DD | 27.15% |
Description: ICHR Ichor Holdings October 23, 2025
Ichor Holdings Ltd (NASDAQ:ICHR) designs, engineers, and manufactures fluid-delivery subsystems and precision components for semiconductor capital equipment. Its product portfolio includes gas delivery modules that regulate etch and deposition gases, and chemical delivery systems that blend reactive liquids for processes such as chemical-mechanical planarization, electroplating, and wafer cleaning. The company also produces specialty parts-weldments, electron-beam and laser-welded components, vacuum-brazed assemblies, and surface-treatment technologies-primarily sold to equipment OEMs, with Japan representing its largest market exposure. Ichor was founded in 1999 and is headquartered in Fremont, California.
Recent data (FY 2023) show Ichor generated approximately $155 million in revenue, with a gross margin of ~38% and a modest operating margin of 4.5%, reflecting the capital-intensive nature of its niche. The semiconductor equipment market is being driven by sustained demand for AI-optimized chips and advanced packaging, which together are projected to grow at a 9-12% CAGR through 2028 (source: SEMI). Ichor’s exposure to gas-delivery systems aligns with the rising share of high-k/metal-gate and EUV-based nodes, where precise gas control is a critical cost driver for fab operators.
For a deeper quantitative view of ICHR’s valuation and peer benchmarks, the ValueRay platform provides a granular breakdown of forward earnings multiples, cash-flow projections, and scenario-based sensitivity analyses.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-40.8m TTM) > 0 and > 6% of Revenue (6% = 57.4m TTM) |
| FCFTA -0.02 (>2.0%) and ΔFCFTA -7.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 29.97% (prev 39.56%; Δ -9.59pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 18.2m > Net Income -40.8m (YES >=105%, WARN >=100%) |
| Net Debt (70.6m) to EBITDA (2.61m) ratio: 27.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.08 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (34.3m) change vs 12m ago 1.92% (target <= -2.0% for YES) |
| Gross Margin 11.58% (prev 11.80%; Δ -0.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 98.57% (prev 83.95%; Δ 14.62pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -4.29 (EBITDA TTM 2.61m / Interest Expense TTM 6.61m) >= 6 (WARN >= 3) |
Altman Z'' 2.78
| (A) 0.30 = (Total Current Assets 424.9m - Total Current Liabilities 138.0m) / Total Assets 966.6m |
| (B) 0.15 = Retained Earnings (Balance) 147.0m / Total Assets 966.6m |
| (C) -0.03 = EBIT TTM -28.3m / Avg Total Assets 971.2m |
| (D) 0.51 = Book Value of Equity 147.0m / Total Liabilities 290.4m |
| Total Rating: 2.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 23.51
| 1. Piotroski 2.0pt |
| 2. FCF Yield -2.72% |
| 3. FCF Margin -1.99% |
| 4. Debt/Equity 0.24 |
| 5. Debt/Ebitda 27.06 |
| 6. ROIC - WACC (= -16.36)% |
| 7. RoE -5.89% |
| 8. Rev. Trend -52.70% |
| 9. EPS Trend -78.46% |
What is the price of ICHR shares?
Over the past week, the price has changed by +5.64%, over one month by +21.24%, over three months by +1.03% and over the past year by -39.95%.
Is ICHR a buy, sell or hold?
- Strong Buy: 5
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ICHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.8 | 28.5% |
| Analysts Target Price | 23.8 | 28.5% |
| ValueRay Target Price | 16.6 | -10.7% |
ICHR Fundamental Data Overview December 24, 2025
P/E Forward = 28.7356
P/S = 0.6598
P/B = 0.9341
P/EG = 0.41
Beta = 1.818
Revenue TTM = 957.3m USD
EBIT TTM = -28.3m USD
EBITDA TTM = 2.61m USD
Long Term Debt = 117.2m USD (from longTermDebt, last quarter)
Short Term Debt = 17.6m USD (from shortTermDebt, last quarter)
Debt = 163.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 70.6m USD (from netDebt column, last quarter)
Enterprise Value = 702.3m USD (631.6m + Debt 163.1m - CCE 92.5m)
Interest Coverage Ratio = -4.29 (Ebit TTM -28.3m / Interest Expense TTM 6.61m)
FCF Yield = -2.72% (FCF TTM -19.1m / Enterprise Value 702.3m)
FCF Margin = -1.99% (FCF TTM -19.1m / Revenue TTM 957.3m)
Net Margin = -4.26% (Net Income TTM -40.8m / Revenue TTM 957.3m)
Gross Margin = 11.58% ((Revenue TTM 957.3m - Cost of Revenue TTM 846.5m) / Revenue TTM)
Gross Margin QoQ = 11.76% (prev 11.32%)
Tobins Q-Ratio = 0.73 (Enterprise Value 702.3m / Total Assets 966.6m)
Interest Expense / Debt = 1.01% (Interest Expense 1.65m / Debt 163.1m)
Taxrate = -3.08% (negative due to tax credits) (683.0k / -22.2m)
NOPAT = -29.2m (EBIT -28.3m * (1 - -3.08%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 3.08 (Total Current Assets 424.9m / Total Current Liabilities 138.0m)
Debt / Equity = 0.24 (Debt 163.1m / totalStockholderEquity, last quarter 676.2m)
Debt / EBITDA = 27.06 (Net Debt 70.6m / EBITDA 2.61m)
Debt / FCF = -3.70 (negative FCF - burning cash) (Net Debt 70.6m / FCF TTM -19.1m)
Total Stockholder Equity = 692.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.22% (Net Income -40.8m / Total Assets 966.6m)
RoE = -5.89% (Net Income TTM -40.8m / Total Stockholder Equity 692.3m)
RoCE = -3.50% (EBIT -28.3m / Capital Employed (Equity 692.3m + L.T.Debt 117.2m))
RoIC = -3.57% (negative operating profit) (NOPAT -29.2m / Invested Capital 818.2m)
WACC = 12.79% (E(631.6m)/V(794.8m) * Re(15.82%) + D(163.1m)/V(794.8m) * Rd(1.01%) * (1-Tc(-0.03)))
Discount Rate = 15.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.08%
Fair Price DCF = unknown (Cash Flow -19.1m)
EPS Correlation: -78.46 | EPS CAGR: -49.39% | SUE: -0.63 | # QB: 0
Revenue Correlation: -52.70 | Revenue CAGR: -4.75% | SUE: 1.39 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=-0.137 | Revisions Net=-4 | Analysts=6
EPS next Year (2026-12-31): EPS=0.73 | Chg30d=-0.354 | Revisions Net=-7 | Growth EPS=+333.0% | Growth Revenue=+4.4%
Additional Sources for ICHR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle